Searched for
NIAID
CDSCO panel gives nod for continuation of phase-II clinical trial of SII's dengue vaccineAn expert committee recommended continuation of phase-II clinical trial of Serum Institute of India's vaccine against dengue after successf...- Dr Anthony Fauci’s final press briefing at White House as NIAID’s outgoing director witnesses chaotic scenesDr Anthony Fauci held his last press conference as the outgoing director of the National Institute of Allergy and Infectious Disease (NIAID...
- Dr. Anthony Fauci, top infectious disease expert, to retire in December"I will be leaving these positions in December of this year to pursue the next chapter of my career," Fauci said in a statement, calling th...
- Study reveals hyperimmune intravenous immunoglobulin doesn't help COVID-19 patientsThe combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remde...
- Experimental mRNA vaccine for HIV shows promise in animalsThe research, which was carried out by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), Moderna and other i...
- Omicron variant 'almost certainly' not more severe than Delta: Anthony FauciAnthony Fauci said results from lab experiments that tested the potency of antibodies from current vaccines against Omicron should come in ...
- Two COVID-19 vaccines for young children show promise in early trials: Study"Safe and effective vaccines for young children will help limit the spread of COVID-19 because we know children can transmit the virus to o...
- 'Not convinced' Covid-19 developed naturally, says Dr FauciWhen Dr. Fauci was asked at an event whether he was still confident that the coronavirus developed naturally he said: "I am not convinced a...
- US health agency questions robustness of AstraZeneca's COVID-19 vaccine trial dataThe Data and Safety Monitoring Board has notified the drugmaker, NIAID and the Biomedical Advanced Research and Development Authority regar...
- Moderna begins study of COVID-19 vaccine in kidsModerna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less ...
- Moderna vaccine confers at least 3 months immunity, shows studyResearchers at the National Institute for Allergies and Infectious Diseases (NIAID), which co-developed the drug, studied the immune respon...
- Moderna vaccine results 'stunningly impressive,' Fauci tells AFP"The idea that we have a 94.5 percent effective vaccine is stunningly impressive. It is really a spectacular result that I don't think anyb...
- US begins first human trial of coronavirus vaccine: OfficialsThe vaccine is called mRNA-1273 and was developed by the NIAID scientists and their collaborators at the biotechnology company Moderna, Inc...
- India, US to add advance manufacturing in their Science and Technology DialogueThe meeting was co-chaired by the Union Science and Technology Minister Dr Harsh Vardhan and John Holdren, Assistant to the President for S...
- India, US to add advance manufacturing in their Science and Technology DialogueA decision in this regard was taken during the India-US S&T Joint Commission Meeting held at the White House.
- To-be-mothers alert! Eating peanuts during infancy is safe for kidsAn important & reassuring finding was that peanut consumption did not affect the duration of breastfeeding, thus countering concerns.
- Experimental Ebola vaccine found safe, effectiveThe experimental vaccine for Ebola, VSV-ZEBOV, has common side effects like site pain and transient fever that appeared and resolved within...
- Ebola vaccine safe for use in Africa, say scientists from NIAIDScientists from the NIAID have developed two experimental DNA vaccines that code for Ebola virus proteins from the Zaire and Sudan strains.
- Experimental Ebola vaccine appears safe in human trialsThe Ebola virus genetic material is delivered by a carrier virus (chimpanzee-derived adenovirus 3 or cAd 3) that causes a common cold in ch...
- Development of rotavirus vaccine a significant victory: USUS today congratulated India for developing an indigenous rotavirus vaccine for prevention of diarrhoea, terming it a significant victory.
Load More
